You are using an older browser version. Please use a supported version for the best MSN experience.

COVID-19 vaccine updates from around the world — these nine candidates are at phase III trial stage

Business Insider India Logo By BI India Bureau of Business Insider India | Slide 1 of 9: Clinical Stage: Phase IIIAstraZeneca-Oxford’s vaccine candidate — ChAdOx1 — is the most advanced COVID-19 candidate in the world. Clinical trials for the most-advanced coronavirus vaccine candidate developed by AstraZeneca and the University of Oxford were put on hold on September 6, over safety concerns. AstraZeneca has resumed trials in Brazil and the UK, but the late-stage trials will remain suspended in the US “for several days.” Despite the halt, the US-based pharma giant says its vaccine could be available this year or by early 2021. In India, Serum Institute too had to pause the trials, however, the Drugs Controller General of India today said it can resume human trials again.

The University of Oxford and AstraZeneca

Clinical Stage: Phase III

AstraZeneca-Oxford’s vaccine candidate — ChAdOx1 — is the most advanced COVID-19 candidate in the world. Clinical trials for the most-advanced coronavirus vaccine candidate developed by AstraZeneca and the University of Oxford were put on hold on September 6, over safety concerns.


AstraZeneca has resumed trials in Brazil and the UK, but the late-stage trials will remain suspended in the US “for several days.” Despite the halt, the US-based pharma giant says its vaccine could be available this year or by early 2021. In India, Serum Institute too had to pause the trials, however, the Drugs Controller General of India today said it can resume human trials again.
© Oxford
image beaconimage beaconimage beacon